[1] Marshall D, Brogi E, Bindi G, et al.Bone density measurement——a systematic review[J].J Inter Med, 1997, 739(suppl):1-60.
[2] Fuerst T.Consensus development conference:Diagnosis, prophylaxis and treatment of osteoprosis[J].Am J Med, 1995, 94:646-650.
[3] Shoukri K.Assement of fracture risk and its application to screening for postmenopausal osteoporosis[A].Shoukri K, Smith J, Genant HK, et al.WHO Techinical Report series 843[C].Geneva:World Heath Organizetion, 1994.56-57.
[4] Kleerekoper M, Nelson DA.Peripheral bone densitometry:an old friend revisited[J].Trans Am Clin Climatol Assoc, 1998, 109:62-70.
[5] Fogelman I, Blake GM.The future of bone density measurements[J].Eur J Nucl Med, 1998, 25(1):1-2.
[6] Blake GM, Rea JA, Fogelnan I.Vertebal morphometry studies using dual x-ray absorptiometry[J].Semin Nucl Med, 1997, 27:276-290.
[7] Njeh CF, Fuerst T, Hans D, et al.Radiation exposure in bone mineral density assessment[J].Appl Radiat Isot, 1999, 50(1):215-236.
[8] Jorgensen HL, Warming L, Bjarnason N H, et al.How does quantitative ultrasound compare to dual X-ray absorptiometry at various skeletal sites in relation to the WHO diagnosis categories?[J].Clin Physiol, 2001, 21(1):9-11.
[9] Dubois EF, van den Bergh JP, Smals AG, et al.Comparison of quantitative ultrasound parameters with dual energy X-ray absorptiometry in pre- and post-menopausal women[J].Neth J Med, 2001, 58(2):62-70.
[10] Ekman A, Michaelsson K, Petren-Mallmin M, et al.DX A of the hip and heel ultrasound but not densitometry of the fingers can discriminate female hip fracture patients from controls:a comparison between four different methods[J].Osteoporos Int, 2001, 12(3):91-93.
[11] Tsurusaki K, Ito M, Hayashi K.Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT)[J].Br J Radiol, 2000, 73(865):14-22.
[12] Reid IR.Preventing glucocoticoid-induced osteoprosis[J].New Engl J Med, 1997, 337:420-421.
[13] Hailey D, Sampietro-colom L, Marshall D, et al.The effectiveness of bone density measurement and associated treatment for prevention of fractures:an international collaborative riew[J].Int J Technol Assesses Health Care, 1998, 14(2):54-237.
[14] 程志强.原发性骨质疏松治疗[J].国外医学内分泌学分册, 1998, 18(2):68-71.
[15] Black DM, Cummings SR, Karpf DB, et al.Randomised trial of effect of alendronate on risk of fracture women with existing vertebral fracture[J].Lancet, 1996, 348:1535-1541.
[16] Compton JE.Designer oestrogen:factor or factory?[J].Lancet, 1997, 350:676-677.